ResMed Announces Conference Call and Webcast to Discuss Third Quarter 2011 Results

SAN DIEGO, April 5, 2011 /PRNewswire/ -- RESMED INC. (NYSE: RMD), announced today that on Thursday, April 28, 2011, it will release its results for the third quarter and nine months of fiscal year 2011, ended March 31, 2011. A press release with ResMed's results will be issued after 1:00 p.m. Pacific Time and the company will host a conference call and webcast to review its results, market trends, and future outlook.

(Logo: https://photos.prnewswire.com/prnh/20100203/RESMEDLOGO)

The conference call is scheduled to begin at 1:30 p.m. Pacific Time and will be webcast on ResMed's website at http://investor.resmed.com. Please go to this section of the website 5-10 minutes prior to the call and click on the icon for the "Q3 2011 results webcast". The online archive of the broadcast will be available approximately 30 minutes after the live call and will continue to be available for two weeks.

International conference call times will be:

9:30 p.m. London

6:30 a.m. Sydney, Australia (April 29, 2011)

TO PARTICIPATE in the conference call, please call one of the numbers below at least 10 minutes before the call begins and identify yourself to the operator:

US:                   617-614-4910

Outside US:           +1 617-614-4910

Conference Name:      Q3 2011 ResMed Inc. Results Conference Call

Participant Passcode: 57596192

The replay of the conference call will be available approximately 30 minutes after the call and will be accessible for two weeks at:

US:         617-801-6888

Outside US: +1 617-801-6888

Passcode:   68716093

ResMed is a leading developer, manufacturer and distributor of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders. The company is dedicated to developing innovative products to improve the lives of those who suffer from these conditions and to increasing awareness among patients and healthcare professionals of the potentially serious health consequences of untreated sleep-disordered breathing. Further information can be obtained by contacting Constance Bienfait at ResMed Inc. at +1 (858) 836-5971, or by visiting the company's Web site at www.resmed.com.

SOURCE RESMED INC.